APA (7th ed.) Citation

Sheridan, M., Maqbool, M. A., Largeot, A., Clayfield, L., Xu, J., Moncaut, N., . . . Lacaud, G. (2024). The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency. Journal of Hematology & Oncology, 17(1), 1. https://doi.org/10.1186/s13045-024-01610-0

Chicago Style (17th ed.) Citation

Sheridan, Mathew, et al. "The Small Inhibitor WM-1119 Effectively Targets KAT6A-rearranged AML, but Not KMT2A-rearranged AML, Despite Shared KAT6 Genetic Dependency." Journal of Hematology & Oncology 17, no. 1 (2024): 1. https://doi.org/10.1186/s13045-024-01610-0.

MLA (9th ed.) Citation

Sheridan, Mathew, et al. "The Small Inhibitor WM-1119 Effectively Targets KAT6A-rearranged AML, but Not KMT2A-rearranged AML, Despite Shared KAT6 Genetic Dependency." Journal of Hematology & Oncology, vol. 17, no. 1, 2024, p. 1, https://doi.org/10.1186/s13045-024-01610-0.